The latest update is out from Bausch Health Companies ( (TSE:BHC) ).
Bausch Health announced a conditional redemption of several series of senior notes, contingent upon the completion of new debt financing transactions. The company plans to issue $4 billion in new senior secured notes due 2032 and secure $3.4 billion in borrowings under a new term loan facility. This strategic financial move aims to optimize the company’s debt structure and potentially enhance its market positioning.
More about Bausch Health Companies
Bausch Health Companies Inc. is a global, diversified pharmaceutical company focused on improving healthcare outcomes. The company develops, manufactures, and markets a wide range of products in areas such as gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health, primarily through its controlling interest in Bausch + Lomb Corporation.
YTD Price Performance: -11.84%
Average Trading Volume: 2,571,613
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.57B
Find detailed analytics on BHC stock on TipRanks’ Stock Analysis page.